Ibandronate Sodium API is a pharmaceutical-grade bisphosphonate used for the prevention and treatment of osteoporosis, particularly in postmenopausal women. It works by inhibiting osteoclast-mediated bone resorption, helping maintain bone density, reduce bone loss, and lower the risk of vertebral fractures.
Ibandronate Sodium is widely formulated into oral tablets and injectable formulations for long-term management of osteoporosis and other metabolic bone disorders. Its proven efficacy and safety profile make it an important active pharmaceutical ingredient in bone health therapies.
Manufactured under WHO-GMP-certified facilities, our Ibandronate Sodium API offers exceptional purity, stability, and batch-to-batch consistency. Every batch is supplied with comprehensive regulatory documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and Product Specifications.
Ibandronate Sodium API is used in pharmaceutical formulations for the prevention and treatment of osteoporosis and other bone disorders.
It inhibits osteoclast activity, reducing bone resorption and helping increase bone mineral density while lowering fracture risk.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation.
Yes. We supply Ibandronate Sodium API in commercial quantities with worldwide export support.
Get Bulk Quote via WhatsApp